nach oben

Journal of Assisted Reproduction and Genetics

Erschienen in:

28.04.2017 | Assisted Reproduction Technologies

National trends and outcomes of autologous in vitro fertilization cycles among women ages 40 years and older

verfasst von: Heather Hipp, Sara Crawford, Jennifer F. Kawwass, Sheree L. Boulet, David A. Grainger, Dmitry M. Kissin, Denise Jamieson

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The purpose of the study was to describe trends in and investigate variables associated with clinical pregnancy and live birth in autologous in vitro fertilization (IVF) cycles among women ≥40 years.

Methods

We used autologous IVF cycle data from the National ART Surveillance System (NASS) for women ≥40 years at cycle start. We assessed trends in fresh and frozen cycles (n = 371,536) from 1996 to 2013. We reported perinatal outcomes and determined variables associated with clinical pregnancy and live birth in fresh cycles between 2007 and 2013.

Results

From 1996 to 2013, the total number of cycles in women ≥40 years increased from 8672 to 28,883 (p < 0.0001), with frozen cycles almost tripling in the last 8 years. Cycles in women ≥40 years accounted for 16.0% of all cycles in 1996 and 21.0% in 2013 (p < 0.0001). For fresh cycles from 2007 to 2013 (n = 157,890), the cancelation rate was 17.1%. Among cycles resulting in transfer (n = 112,414), the live birth rate was 16.1%. The following were associated with higher live birth rates: multiparity, fewer prior ART cycles, use of standard agonist or antagonist stimulation, lower gonadotropin dose, ovarian hyperstimulation syndrome, more oocytes retrieved, use of pre-implantation genetic screening/diagnosis, transferring more and/or blastocyst stage embryos, and cryopreserving more supernumerary embryos. Of the singleton infants born (n = 14,992), 86.9% were full term and 88.3% normal birth weight.

Conclusions

The NASS allows for a comprehensive description of IVF cycles in women ≥40 years in the USA. Although live birth rate is less than 20%, identifying factors associated with IVF success can facilitate treatment option counseling.

Mills M, Rindfuss RR, McDonald P, te Velde E, Reproduction E, Society Task F. Why do people postpone parenthood? Reasons and social policy incentives. Hum Reprod Update. 2011;17(6):848–60. doi:10.1093/humupd/dmr026.CrossRefPubMedPubMedCentral

Martin JA, Hamilton BE, Osterman MJ, Curtin SC, Matthews TJ. Births: final data for 2013. Natl Vital Stat Rep. 2015;64(1):1–65.

Eijkemans MJ, van Poppel F, Habbema DF, Smith KR, Leridon H, te Velde ER. Too old to have children? Lessons from natural fertility populations. Hum Reprod. 2014;29(6):1304–12. doi:10.1093/humrep/deu056.CrossRefPubMedPubMedCentral

Klipstein S, Regan M, Ryley DA, Goldman MB, Alper MM, Reindollar RH. One last chance for pregnancy: a review of 2,705 in vitro fertilization cycles initiated in women age 40 years and above. Fertil Steril. 2005;84(2):435–45. doi:10.1016/j.fertnstert.2005.02.020.CrossRefPubMed

Tsafrir A, Simon A, Revel A, Reubinoff B, Lewin A, Laufer N. Retrospective analysis of 1217 IVF cycles in women aged 40 years and older. Reprod BioMed Online. 2007;14(3):348–55.CrossRefPubMed

Gleicher N, Vega MV, Darmon SK, Weghofer A, Wu YG, Wang Q, et al. Live-birth rates in very poor prognosis patients, who are defined as poor responders under the Bologna criteria, with nonelective single embryo, two-embryo, and three or more embryos transferred. Fertil Steril. 2015;104(6):1435–41. doi:10.1016/j.fertnstert.2015.08.023.CrossRefPubMed

Patrizio P, Sakkas D. From oocyte to baby: a clinical evaluation of the biological efficiency of in vitro fertilization. Fertil Steril. 2009;91(4):1061–6. doi:10.1016/j.fertnstert.2008.01.003.CrossRefPubMed

Serour G, Mansour R, Serour A, Aboulghar M, Amin Y, Kamal O, et al. Analysis of 2,386 consecutive cycles of in vitro fertilization or intracytoplasmic sperm injection using autologous oocytes in women aged 40 years and above. Fertil Steril. 2010;94(5):1707–12. doi:10.1016/j.fertnstert.2009.09.044.CrossRefPubMed

Orvieto R, Bar-Hava I, Yoeli R, Ashkenazi J, Rabinerson D, Bar J, et al. Results of in vitro fertilization cycles in women aged 43-45 years. Gynecol Endocrinol. 2004;18(2):75–8.CrossRefPubMed

10.

Maheshwari A, Scotland G, Bell J, McTavish A, Hamilton M, Bhattacharya S. Direct health services costs of providing assisted reproduction services in older women. Fertil Steril. 2010;93(2):527–36. doi:10.1016/j.fertnstert.2009.01.115.CrossRefPubMed

11.

Caplan AL, Patrizio P. Are you ever too old to have a baby? The ethical challenges of older women using infertility services. Semin Reprod Med. 2010;28(4):281–6. doi:10.1055/s-0030-1255175.CrossRefPubMed

12.

Salem Yaniv S, Levy A, Wiznitzer A, Holcberg G, Mazor M, Sheiner E. A significant linear association exists between advanced maternal age and adverse perinatal outcome. Arch Gynecol Obstet. 2011;283(4):755–9. doi:10.1007/s00404-010-1459-4.CrossRefPubMed

13.

Wennberg AL, Opdahl S, Bergh C, Aaris Henningsen AK, Gissler M, Romundstad LB, et al. Effect of maternal age on maternal and neonatal outcomes after assisted reproductive technology. Fertil Steril. 2016;106(5):1142–1149 e14. doi:10.1016/j.fertnstert.2016.06.021.CrossRefPubMed

14.

Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2013 assisted reproductive technology fertility clinic success rates report. Atlanta: US Dept of Health and Human Services; 2015.

15.

Kissin DM, Crawford S, Boulet SL. The status of public reporting of clinical outcomes in assisted reproductive technology. Fertil Steril. 2013;100(3):e16–7. doi:10.1016/j.fertnstert.2013.07.199.CrossRefPubMedPubMedCentral

16.

Kushnir VA, Barad DH, Albertini DF, Darmon SK, Gleicher N. Effect of embryo banking on U.S. National Assisted Reproductive Technology Live Birth Rates. PLoS One. 2016;11(5):e0154620. doi:10.1371/journal.pone.0154620.CrossRefPubMedPubMedCentral

17.

Toner JP, Coddington CC, Doody K, Van Voorhis B, Seifer DB, Ball GD, et al. Society for Assisted Reproductive Technology and assisted reproductive technology in the United States: a 2016 update. Fertil Steril. 2016;106(3):541–6. doi:10.1016/j.fertnstert.2016.05.026.CrossRefPubMed

18.

Sunderam S, Kissin DM, Crawford SB, Folger SG, Jamieson DJ, Warner L, et al. Assisted Reproductive Technology Surveillance—United States, 2013. MMWR Surveill Summ. 2015;64(11):1–25. doi:10.15585/mmwr.ss6411a1.CrossRef

19.

Kenny LC, Lavender T, McNamee R, O’Neill SM, Mills T, Khashan AS. Advanced maternal age and adverse pregnancy outcome: evidence from a large contemporary cohort. PLoS One. 2013;8(2):e56583. doi:10.1371/journal.pone.0056583.CrossRefPubMedPubMedCentral

20.

Spandorfer SD, Bendikson K, Dragisic K, Schattman G, Davis OK, Rosenwaks Z. Outcome of in vitro fertilization in women 45 years and older who use autologous oocytes. Fertil Steril. 2007;87(1):74–6. doi:10.1016/j.fertnstert.2006.05.081.CrossRefPubMed

21.

Gunnala V, Reichman DE, Meyer L, Davis OK, Rosenwaks Z. Beyond the American Society for Reproductive Medicine transfer guidelines: how many cleavage-stage embryos are safe to transfer in women ≥43 years old? Fertil Steril. 2014;102(6):1626–1632 e1. doi:10.1016/j.fertnstert.2014.09.015.CrossRefPubMed

22.

Hill MJ, Richter KS, Heitmann RJ, Lewis TD, DeCherney AH, Graham JR, et al. Number of supernumerary vitrified blastocysts is positively correlated with implantation and live birth in single-blastocyst embryo transfers. Fertil Steril. 2013;99(6):1631–6. doi:10.1016/j.fertnstert.2013.01.130.CrossRefPubMedPubMedCentral

23.

Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertil Steril. 2015;104(5):1145–1152 e1-5. doi:10.1016/j.fertnstert.2015.07.1151.CrossRefPubMedPubMedCentral

24.

Steiner AZ, Jukic AM. Impact of female age and nulligravidity on fecundity in an older reproductive age cohort. Fertil Steril. 2016;105(6):1584–1588 e1. doi:10.1016/j.fertnstert.2016.02.028.CrossRefPubMedPubMedCentral

25.

Malacova E, Kemp A, Hart R, Jama-Alol K, Preen DB. Effectiveness of in vitro fertilization in women with previous tubal sterilization. Contraception. 2015;91(3):240–4. doi:10.1016/j.contraception.2014.12.001.CrossRefPubMed

26.

Kalra SK, Ratcliffe SJ, Dokras A. Is the fertile window extended in women with polycystic ovary syndrome? Utilizing the Society for Assisted Reproductive Technology registry to assess the impact of reproductive aging on live-birth rate. Fertil Steril. 2013;100(1):208–13. doi:10.1016/j.fertnstert.2013.02.055.CrossRefPubMed

Titel: National trends and outcomes of autologous in vitro fertilization cycles among women ages 40 years and older
verfasst von: Heather Hipp
Sara Crawford
Jennifer F. Kawwass
Sheree L. Boulet
David A. Grainger
Dmitry M. Kissin
Denise Jamieson
Publikationsdatum: 28.04.2017
Verlag: Springer US
Erschienen in: Journal of Assisted Reproduction and Genetics / Ausgabe 7/2017
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI: https://doi.org/10.1007/s10815-017-0926-2

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

National trends and outcomes of autologous in vitro fertilization cycles among women ages 40 years and older